Back to discover
Drug

Selenium

In clinical development
Emerging researchLate-stage developmentCooling momentum
Also known as Se, Se - Selenium, Selen, Selenium elemental+4 more

Se, Se - Selenium, Selen, Selenium elemental, Selenium metallicum, Selenium, elemental, Selenio, Sélénium.

8
Research papers
1
Active clinical trials
Latest activity
beta

Recent clinical, regulatory, research and industry developments relating to this drug.

Effect of Melatonin in Peripartum Cardiomyopathy

Clinical trial2026-01-12Results expected Q4 2029 · ClinicalTrials.gov

Impact of Selenium on Methotrexate Induced Spermatotoxicity; A Comparative Study

Clinical trial2024-12-31Completed · ClinicalTrials.gov

Understanding How Minerals Contribute to Optimal Immune Function.

Research2023-11-01Journal of immunology research

Profile

Identifiers & mechanism

Canonical identifiers, marketed brand names and mechanism, resolved across RxNorm, ChEMBL and ATC.

Canonical name
Selenium
Aliases & brands
SeSe - SeleniumSelenSelenium elementalSelenium metallicumSelenium, elementalSelenioSélénium
RxNorm CUI
9641
ChEMBL ID
CHEMBL6068503
UNII
H6241UJ22B

Clinical trials

34 trials

The current development programme across all trial phases — status mix, phase distribution and the late-stage studies shaping the evidence base.

Development programme
CLINICALTRIALS.GOV · LIVE REGISTRY
34
registered trials across all phases
LATEST COMPLETION 2025
1
Active studies
1
Recruiting
23
Late-stage (III+)
20
Completed
13
Discontinued
PHASE DISTRIBUTIONn = 34
Early Phase 11Phase 15Phase 1 / 23Phase 22Phase 2 / 33Phase 311Phase 44Phase N / A5

Late-stage studies

Phase III+ trials still open or recently active — where late-stage evidence is being generated.

Recent completions

Trials that read out recently, adding to the completed evidence base.

Research activity

8 papers

Key research shaping understanding of this drug, combining the latest publications with the most influential evidence.

Publications over time
20202025
Recent papers
Major research themes8
Selenium5Dietary Supplements2Alzheimer Disease1Fatigue Syndrome, Chronic1Ferroptosis1Gastrointestinal Microbiome1Hashimoto Disease1Immune System1
Journals, researchers & institutions
Top journals
  • Nutrients2
  • Frontiers in endocrinology1
  • International journal of molecular sciences1
  • Journal of immunology research1
  • Molecular medicine reports1
  • Redox biology1
Leading researchers
  • Amrein K1
  • Asaad S1
  • Ayton S1
  • Baj J1
  • Bargieł J1
  • Bogdan Goroftei ER1
  • Bush AI1
  • Butnariu IA1
Leading institutions
free-text, unnormalised
  • "Apollonia" University of Iasi1
  • "Grigore T. Popa" University of Medicine and Pharmacy1
  • Clinica Medica "A. Murri"1
  • Department of Epidemiology and Clinical Research Methodology1
  • Department of Laboratory Medicine1
  • Department of Neurology and State Key Laboratory of Biotherapy1

Related diseases

2 conditions

Regulator-approved indications and conditions co-mentioned with this drug across the research literature. Number shows shared papers.

Related drugs

7 matches

Drugs sharing diseases, protein targets and literature with this one. Ranked by graph evidence (shared targets + diseases weighted above co-mentions).

Studied across 7 of the same disease areas as Selenium in the shared literature.

7 shared diseases2 shared papers

Studied across 7 of the same disease areas as Selenium in the shared literature.

7 shared diseases1 shared paper

Studied across 6 of the same disease areas as Selenium in the shared literature.

6 shared diseases1 shared paper

Studied across 6 of the same disease areas as Selenium in the shared literature.

6 shared diseases1 shared paper

Studied across 2 of the same disease areas as Selenium in the shared literature.

2 shared diseases1 shared paper

Studied across the same disease area as Selenium in the shared literature.

1 shared disease1 shared paper

Frequently co-studied with Selenium in the research literature.

1 shared paper
References & data sources
  • RxNorm (U.S. National Library of Medicine) — drug identity
  • ChEMBL (EMBL-EBI) & UniProt — pharmacology and targets
  • Europe PMC — research literature
  • ClinicalTrials.gov — clinical trials